Artiva Biotherapeutics, Inc.
ARTV- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817241
In the last 90 days, Artiva Biotherapeutics, Inc. insiders filed 5 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $391.6M in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Artiva Biotherapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −8 vs. Q2 2025
- Shares held
- 18.2M
- −355.0K (−1.9%) vs. Q2 2025
- Total value
- $52.1M
- +$24.2M (+86.4%) vs. Q2 2025
- New holders
- 6
- 8 more added
- Sold out
- 14
- 16 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARTV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $391.6M |
| Q1 2026 | 40 | $108.4M |
| Q4 2025 | 34 | $72.7M |
| Q3 2025 | 40 | $52.1M |
| Q2 2025 | 48 | $27.9M |
| Q1 2025 | 53 | $62.8M |
| Q4 2024 | 57 | $213.2M |
| Q3 2024 | 49 | $319.4M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Artiva Biotherapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 9,853,302 | $28.3M | 0.35% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 2,353,304 | $6.75M | 2.47% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,609,569 | $4.62M | 0.26% | 00.0% | Unchanged |
| venBio Partners LLC | 1,148,975 | $3.30M | 1.87% | 00.0% | Unchanged |
| Citadel Advisors LLC | 798,397 | $2.29M | 0.00% | +644,658+419.3% | Added |
| Franklin Resources Inc | 520,327 | $1.49M | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 294,422 | $845.0K | 0.00% | −191,305−39.4% | Reduced |
| Millennium Management LLC | 262,160 | $752.4K | 0.00% | −64,907−19.8% | Reduced |
| Wellington Management Group LLP | 194,108 | $557.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 159,118 | $456.7K | 0.00% | −73,854−31.7% | Reduced |
| BNP Paribas Arbitrage, SA | 118,547 | $340.2K | 0.00% | +117,733+14,463.5% | Added |
| Geode Capital Management, LLC | 110,896 | $318.5K | 0.00% | −48,145−30.3% | Reduced |
| Citigroup Inc | 105,573 | $303.0K | 0.00% | +102,006+2,859.7% | Added |
| Alyeska Investment Group, L.P. | 100,000 | $287.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 79,147 | $227.2K | 0.00% | +79,147 | New |
| State Street Corp | 59,824 | $171.7K | 0.00% | −3,050−4.9% | Reduced |
| Goldman Sachs Group Inc | 49,777 | $142.9K | 0.00% | −68,226−57.8% | Reduced |
| XTX Topco Ltd | 47,973 | $137.7K | 0.01% | +47,973 | New |
| Morgan Stanley | 42,829 | $122.9K | 0.00% | −3,418−7.4% | Reduced |
| Landscape Capital Management, L.L.C. | 39,133 | $112.3K | 0.01% | +39,133 | New |
| Bridgeway Capital Management, LLC | 35,000 | $100.5K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 26,953 | $77.0K | 0.00% | −50,703−65.3% | Reduced |
| Qube Research & Technologies Ltd | 25,552 | $73.3K | 0.00% | −13,140−34.0% | Reduced |
| UBS Group AG | 21,143 | $60.7K | 0.00% | +17,806+533.6% | Added |
| Two Sigma Investments, LP | 20,364 | $58.4K | 0.00% | −1,007−4.7% | Reduced |
| Bank of America Corp | 16,145 | $46.3K | 0.00% | +11,190+225.8% | Added |
| Prelude Capital Management, LLC | 14,302 | $41.0K | 0.00% | +14,302 | New |
| Barclays PLC | 12,696 | $36.4K | 0.00% | +10,790+566.1% | Added |
| Tower Research Capital LLC (TRC) | 9,981 | $28.6K | 0.00% | −117−1.2% | Reduced |
| Russell Investments Group, Ltd. | 5,491 | $15.8K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 4,920 | $14.1K | 0.00% | −37,357−88.4% | Reduced |
| China Universal Asset Management Co., Ltd. | 4,281 | $12.3K | 0.00% | −612−12.5% | Reduced |
| JPMorgan Chase & Co | 4,002 | $11.5K | 0.00% | +3,137+362.7% | Added |
| Wells Fargo & Company | 1,700 | $4.88K | 0.00% | −364−17.6% | Reduced |
| Royal Bank of Canada | 840 | $3.00K | 0.00% | −280−25.0% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 944 | $2.71K | 0.00% | +3+0.3% | Added |
| GF Fund Management Co. Ltd. | 510 | $1.46K | 0.00% | −93−15.4% | Reduced |
| Mark Sheptoff Financial Planning, LLC | 400 | $1.15K | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 159 | $456 | 0.00% | +159 | New |
| Cloud Capital Management, LLC | 11 | $0 | 0.00% | +11 | New |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −291,666−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −283,124−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −52,213−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −45,456−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −44,215−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −41,395−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −34,964−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −31,567−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −24,849−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −17,171−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,121−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −3,383−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −329−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |